Leading the Charge by Dr. Rahul Ravilla: The Newer Immune-Related Side-Effects Impacts Continuity of Care in Individuals with Cancer on Immune Checkpoint Inhibitors

Journal: International Research Journal of Pharmacy and Medical Sciences (IRJPMS) (Vol.2, No. 3)

Publication Date: 2019-05-10

Authors : Sumit N Fogla;

Page : 35-37

Keywords : ;

Source : Download Find it from : Google Scholar

Abstract

Immunotherapy agents for treatment of cancer have been explored for several decades, but effective drugs have only recently been identified and are increasingly being used in multiple cancer types.

Main Menu

Searching By

PARTNERS

Leading the Charge by Dr. Rahul Ravilla: The Newer Immune-Related Side-Effects Impacts Continuity of Care in Individuals with Cancer on Immune Checkpoint Inhibitors

Abstract

Advertisement